Literature DB >> 19411311

Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells.

Toni R Bartling1, Mitchell L Drumm.   

Abstract

Inflammatory cytokines, particularly the neutrophil chemoattractant IL-8, are elevated in the cystic fibrosis (CF) airway, even in the absence of detectable infection. The transcriptional regulation of many inflammatory genes, including IL8 (CXCL8), involves chromatin remodeling through histone acetylation. NF-kappaB is known to facilitate histone acetylation of IL8 and other proinflammatory gene promoters, but we find that increased NF-kappaB activation cannot explain the elevated IL8 expression and promoter acetylation seen in CFTR-deficient cells. Recognized components of the NF-kappaB-coactivator complex, acetyltransferase CBP, p300, and the histone deacetylase HDAC1, are unchanged by CFTR activity. However, we find that the histone acetyltransferase (HAT)/HDAC balance is sensitive to CFTR function, as cells with reduced or absent CFTR function have decreased HDAC2 protein, resulting in hyperacetylation of the IL8 promoter and increased IL8 transcription. Reduced HDAC2 and HDAC2 activity, but not HDAC2 mRNA, is observed in cells deficient in CFTR. Suppressing HDAC2 expression with HDAC2 short hairpin RNA (shRNA) results in increased IL8 expression and promoter acetylation comparable with CFTR-deficient cells. Treating CFTR-deficient cells with N-acetyl-cysteine (NAC) increases HDAC2 expression to near control levels. Our data suggest that there is an intrinsic alteration in the HAT/HDAC balance in cells lacking CFTR function in vitro and in native CF tissue and that oxidative stress is likely contributing to this alteration. This mechanism, found in other inflammatory airway diseases, provides an explanation for the apparent dysregulation of inflammatory mediators seen in the CF airway, as reduced histone deacetylation would potentially influence many genes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411311      PMCID: PMC2711807          DOI: 10.1152/ajplung.90399.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  57 in total

1.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.

Authors:  Kazuhiro Ito; Sam Lim; Gaetano Caramori; Borja Cosio; K Fan Chung; Ian M Adcock; Peter J Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

2.  Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles.

Authors:  Peter S Gilmour; Irfan Rahman; Kenneth Donaldson; William MacNee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11-22       Impact factor: 5.464

3.  Expression and activity of histone deacetylases in human asthmatic airways.

Authors:  Kazuhiro Ito; Gaetano Caramori; Sam Lim; Tim Oates; K Fan Chung; Peter J Barnes; Ian M Adcock
Journal:  Am J Respir Crit Care Med       Date:  2002-08-01       Impact factor: 21.405

4.  The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2.

Authors:  Oliver H Krämer; Ping Zhu; Heather P Ostendorff; Martin Golebiewski; Jens Tiefenbach; Marvin A Peters; Boris Brill; Bernd Groner; Ingolf Bach; Thorsten Heinzel; Martin Göttlicher
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

Review 5.  Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase.

Authors:  Peter J Barnes; Kazuhiro Ito; Ian M Adcock
Journal:  Lancet       Date:  2004-02-28       Impact factor: 79.321

Review 6.  Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases.

Authors:  Irfan Rahman
Journal:  J Biochem Mol Biol       Date:  2003-01-31

7.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration.

Authors:  K Ito; T Hanazawa; K Tomita; P J Barnes; I M Adcock
Journal:  Biochem Biophys Res Commun       Date:  2004-02-27       Impact factor: 3.575

8.  The effect of oxidative stress on histone acetylation and IL-8 release.

Authors:  K Tomita; P J Barnes; I M Adcock
Journal:  Biochem Biophys Res Commun       Date:  2003-02-07       Impact factor: 3.575

9.  Role for cystic fibrosis transmembrane conductance regulator protein in a glutathione response to bronchopulmonary pseudomonas infection.

Authors:  Brian J Day; Anna M van Heeckeren; Elysia Min; Leonard W Velsor
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

10.  Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.

Authors:  Borja G Cosio; Loukia Tsaprouni; Kazuhiro Ito; Elen Jazrawi; Ian M Adcock; Peter J Barnes
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

View more
  14 in total

1.  Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase.

Authors:  Obi C Umunakwe; Adam C Seegmiller
Journal:  J Lipid Res       Date:  2014-05-24       Impact factor: 5.922

Review 2.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

Review 3.  Overcoming reduced glucocorticoid sensitivity in airway disease: molecular mechanisms and therapeutic approaches.

Authors:  John A Marwick; Ian M Adcock; Kian Fan Chung
Journal:  Drugs       Date:  2010-05-28       Impact factor: 9.546

4.  CFTR inhibition provokes an inflammatory response associated with an imbalance of the annexin A1 pathway.

Authors:  Jesmond Dalli; Guglielmo Rosignoli; Richard P G Hayhoe; Aleksander Edelman; Mauro Perretti
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

5.  Reduced microtubule acetylation in cystic fibrosis epithelial cells.

Authors:  Sharon M Rymut; Alyssa Harker; Deborah A Corey; James D Burgess; Hongtao Sun; John P Clancy; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-07-19       Impact factor: 5.464

6.  Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression.

Authors:  Toni R Bartling; Sita Subbaram; Ryan R Clark; Akshaya Chandrasekaran; Supriya Kar; J Andres Melendez
Journal:  Free Radic Biol Med       Date:  2014-06-25       Impact factor: 7.376

7.  Epigenetic modifying enzyme expression in asthmatic airway epithelial cells and fibroblasts.

Authors:  Dorota Stefanowicz; Jari Ullah; Kevin Lee; Furquan Shaheen; Ekiomoado Olumese; Nick Fishbane; Hyun-Kyoung Koo; Teal S Hallstrand; Darryl A Knight; Tillie-Louise Hackett
Journal:  BMC Pulm Med       Date:  2017-01-31       Impact factor: 3.317

8.  Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (Triple I): randomized clinical trial.

Authors:  Catalin S Buhimschi; Mert Ozan Bahtiyar; Guomao Zhao; Osama Abdelghany; Lydia Schneider; Sonya Abdel Razeq; Antonette T Dulay; Heather S Lipkind; Saya Mieth; Lynette Rogers; Vineet Bhandari; Irina A Buhimschi
Journal:  Pediatr Res       Date:  2020-08-20       Impact factor: 3.756

9.  Normal CFTR inhibits epidermal growth factor receptor-dependent pro-inflammatory chemokine production in human airway epithelial cells.

Authors:  Suil Kim; Brittney A Beyer; Courtney Lewis; Jay A Nadel
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

Review 10.  Role of Cystic Fibrosis Bronchial Epithelium in Neutrophil Chemotaxis.

Authors:  Giulio Cabrini; Alessandro Rimessi; Monica Borgatti; Ilaria Lampronti; Alessia Finotti; Paolo Pinton; Roberto Gambari
Journal:  Front Immunol       Date:  2020-08-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.